TORTI, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 8.653
AS - Asia 5.283
EU - Europa 2.279
SA - Sud America 1.244
Continente sconosciuto - Info sul continente non disponibili 264
AF - Africa 145
OC - Oceania 11
Totale 17.879
Nazione #
US - Stati Uniti d'America 8.351
SG - Singapore 2.471
CN - Cina 1.135
IT - Italia 1.029
BR - Brasile 932
VN - Vietnam 561
IN - India 537
GB - Regno Unito 301
SE - Svezia 261
DE - Germania 219
CA - Canada 186
HK - Hong Kong 148
BD - Bangladesh 107
AR - Argentina 105
FI - Finlandia 82
MX - Messico 74
NL - Olanda 68
EC - Ecuador 60
ID - Indonesia 55
IQ - Iraq 53
FR - Francia 41
RU - Federazione Russa 41
CO - Colombia 38
PL - Polonia 37
VE - Venezuela 34
ES - Italia 33
UA - Ucraina 33
ZA - Sudafrica 33
TR - Turchia 32
PY - Paraguay 28
CZ - Repubblica Ceca 26
JP - Giappone 26
CL - Cile 25
RO - Romania 22
UZ - Uzbekistan 22
EG - Egitto 21
SA - Arabia Saudita 21
PK - Pakistan 20
KE - Kenya 18
TN - Tunisia 16
MA - Marocco 12
AE - Emirati Arabi Uniti 11
IL - Israele 11
IE - Irlanda 10
PE - Perù 10
A2 - ???statistics.table.value.countryCode.A2??? 9
DZ - Algeria 9
AT - Austria 8
CR - Costa Rica 8
DO - Repubblica Dominicana 8
LT - Lituania 8
PH - Filippine 8
SC - Seychelles 8
ET - Etiopia 7
NG - Nigeria 7
UY - Uruguay 7
AL - Albania 6
AU - Australia 6
AZ - Azerbaigian 6
CH - Svizzera 6
EE - Estonia 6
JM - Giamaica 6
JO - Giordania 6
KZ - Kazakistan 6
AM - Armenia 5
BG - Bulgaria 5
BO - Bolivia 5
EU - Europa 5
GR - Grecia 5
GT - Guatemala 5
NP - Nepal 5
BY - Bielorussia 4
IR - Iran 4
KR - Corea 4
LB - Libano 4
NO - Norvegia 4
TW - Taiwan 4
BE - Belgio 3
BH - Bahrain 3
KG - Kirghizistan 3
KH - Cambogia 3
LV - Lettonia 3
MY - Malesia 3
RS - Serbia 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
CI - Costa d'Avorio 2
DK - Danimarca 2
GH - Ghana 2
HN - Honduras 2
HR - Croazia 2
MD - Moldavia 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TO - Tonga 2
Totale 17.604
Città #
San Jose 1.627
Chandler 900
Singapore 894
Ashburn 768
Santa Clara 458
Bengaluru 398
Hefei 396
Dallas 374
Milan 347
Princeton 334
Lawrence 332
Council Bluffs 321
Chicago 227
London 222
Wilmington 216
Ho Chi Minh City 209
Munich 163
Beijing 157
Hong Kong 137
Ottawa 124
Hanoi 123
Des Moines 98
São Paulo 83
Los Angeles 80
Boardman 72
New York 66
Turku 64
Rome 62
Pune 36
Brooklyn 35
San Francisco 34
Shanghai 33
Guangzhou 32
Haiphong 32
Norwalk 32
Chennai 31
The Dalles 31
Catanzaro 29
Palermo 29
Redwood City 29
Rio de Janeiro 27
Olomouc 26
Warsaw 26
Montreal 25
Da Nang 24
Guayaquil 23
Mexico City 23
Atlanta 22
Baghdad 22
Tokyo 22
Woodbridge 22
Belo Horizonte 21
Houston 21
Crotone 20
San Nicola Manfredi 20
Tashkent 20
Wuhan 20
Thái Bình 19
Naples 18
Orem 18
Salvador 18
Stockholm 18
Boston 17
Fairfield 17
Helsinki 17
Buffalo 16
Phoenix 16
Porto Alegre 16
Quito 16
Nairobi 15
Seattle 15
Amsterdam 14
Asunción 14
Brasília 14
Jakarta 14
Shenzhen 14
Bogotá 13
Charlotte 13
Cosenza 13
Piracicaba 13
Caracas 12
Curitiba 12
Hanover 12
Johannesburg 12
Rende 12
Rui'an 12
Ankara 11
Biên Hòa 11
Redmond 11
Bari 10
Settingiano 10
Buenos Aires 9
Columbus 9
Denver 9
Dhaka 9
Guarulhos 9
Manchester 9
Miami 9
Mumbai 9
Padova 9
Totale 10.583
Nome #
Severe hepatotoxicity during combination antiretroviral treatment: Incidence, liver histology, and outcome 120
Analysis of the persistence time of the SARS-CoV-2 virus in the cadaver and the risk of passing infection to autopsy staff 110
The Role of Gut Microbiota in the Clinical Outcome of Septic Patients: State of the Art and Future Perspectives 98
A case report of pneumomediastinum in a COVID-19 patient treated with high-flow nasal cannula and review of the literature: Is this a “spontaneous” complication? 93
Increasing clinical virulence in two decades of the Italian HIV epidemic 86
A Rare Complication of Ascariasis: A Case of Acute Interstitial Nephritis 84
A CASE REPORT OF SCHISTOSOMA HAEMATOBIUM INFECTION IN A PREGNANT MIGRANT RAISES CONCERNS ABOUT LACK OF SCREENING POLICIES. 83
The spike-specific TCRβ repertoire shows distinct features in unvaccinated or vaccinated patients with SARS-CoV-2 infection 82
Varicella zoster immunity loss in multiple sclerosis patient treated with ocrelizumab 81
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients 79
Ochrobactrum anthropi 79
Multidisciplinary approach to a septic COVID-19 patient undergoing veno-venous extracorporeal membrane oxygenation and receiving thoracic surgery 79
Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility 78
Adaptive optics optical coherence tomography at 120,000 depth scans/s for non-invasive cellular phenotyping of the living human retina 77
Use of colistin in adult patients: a cross-sectional study 77
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: results from the EPOKA-MASTER Cohort. 75
Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19 75
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape 74
Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital 74
EFFICACY OF CEFIDEROCOL- VERSUS COLISTIN-CONTAINING REGIMEN FOR TREATMENT OF BACTEREMIC VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII IN COVID-19 PATIENTS 73
Evolving phenotypes of non-hospitalized patients that indicate long COVID 70
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: The resistance and dosage adapted regimens (RADAR) study 69
Predictors of long-term immunological outcome in rebounding patients on protease inhibitor-based HAART after initial successful virologic suppression: Implications for timing to switch 69
Challenging clinical cases in HCV infection 69
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 68
Knowledge of HIV infection and transmission: a knowledge, attitudes, beliefs and practices (KABP) survey among a sample of students at the "Magna Graecia", University of Catanzaro 68
Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study based on electronic health records through the 4CE consortium 67
A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy 67
Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography, especially in obese individuals 67
Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. Higher rates of triple-class virological failure in perinatally HIV infected teenagers compared with heterosexually infected young adults in Europe 67
Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report series. 67
Molecular recognition studies of dasabuvir, tegobuvir, and setrobuvir against natural Hepatitis C Virus NS5B polymerase variants. 67
Characteristics, management, and outcomes of elderly patients with diabetes in a covid-19 unit: Lessons learned from a pilot study 67
Allozyme divergence and phylogenetic relationships among species of tephritid flies 66
Adiponectin serum level in chronic hepatitis C infection and therapeutic profile 66
Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report. 66
Direct antimicrobial susceptibility testing (AST) from positive blood cultures using Microscan system for early detection of bacterial resistance phenotypes 66
The role of Gram-negative bacteria in skin and soft tissue infections 65
Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study 65
Therapy with RAS inhibitors during the COVID-19 pandemic 65
A new basal subfamily of mariner elements in Ceratitis rosa and other tephritid flies 64
A Randomized, Pilot Trial to Evaluate Glomerular Filtration Rate by Creatinine or Cystatin C in Naive HIV-Infected Patients After Tenofovir/Emtricitabine in Combination With Atazanavir/Ritonavir or Efavirenz 64
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study 64
Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV-patients with cirrhosis. 64
A king in the CASTLE? Optimum initial HIV protease inhibitor. 63
RegaDB: community-driven data management and analysis for infectious diseases 63
2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings. 63
Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience 63
Touching Base with Some Mediterranean Diseases of Interest from Paradigmatic Cases at the “Magna Graecia” University Unit of Infectious Diseases: A Didascalic Review 62
Virologic and resistance markers in HIV infection: rationale, state of ART and perspective in clinical practice 62
A randomized, controlled trial of triple antiviral therapy as initial treatment of chronic hepatitis C in HIV-infected patients 62
Effectiveness of adjunctive gabapentin in resistant bipolar disorder: Is it due to anxious-alcohol abuse comorbidity? 62
HCV antibody prevalence and genotype evolution in a teaching hospital, Calabria Region, southern Italy over a decade (2008-2018) 62
Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility 62
Discussion on critical points for a tailored therapy to cure hepatitis C virus infection 61
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 61
HIV-1 pharmacoresistance: clinical and therapeutic implications 61
Response to combination antiretroviral therapy: variation by age - The Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study group 61
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy 61
y CD4 Cell Count and the Risk of AIDS or Death in HIV-Infected Adults on Combination Antiretroviral Therapy with a Suppressed Viral Load: A Longitudinal Cohort Study from COHERE 61
Analysis of dominant viral populations isolated from two pediatric patients infected by HCV genotype 4. 61
Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy 61
Is the Pendulum of Antimicrobial Drug Resistance Swinging Back after COVID-19? 60
Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients. 60
A case report of nasopharyngeal carcinoma in a Caucasian Italian man 60
Depression of lymphocyte activity during cutaneous leishmaniasis: a case report. 60
Listeria infection after treatment with alemtuzumab: A case report and literature review. would antibiotic prophylaxis be considered? 60
Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral Treatment 59
Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort 59
Back to the origin of HCV 2c subtype and spreading to the Calabria region (Southern Italy) over the last two centuries: A phylogenetic study 59
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering 58
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium 58
Role of IgG and IgM and proinflammatory aspecific markers in the diagnosis and prognosis of COVID-19 patients stratified by number of positive SARS-CoV-2 genes 58
Genetic aspects of the worldwide colonization process of Ceratitis capitata 57
Prospective evaluation of bone markers, parathormone and 1,25-(OH)(2) vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz 57
Is response to anti-hepatitis C virus treatment predictive of mortality in hepatitis C virus/HIV-positive patients? The Hepatitis C Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord 57
Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report 57
Weight of Clinical and Social Determinants of Metabolic Syndrome in People Living with HIV 57
A population-based database to study malignancies in HIV-infected patients in the Local Health Unit of Brescia (Northern Italy), period 1999-2009 56
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy 56
Calendar Time Trends in the Incidence and Prevalence of Triple-Class Virologic Failure in Antiretroviral Drug-Experienced People With HIV in Europe 56
Virological Mechanisms in the Coinfection between HIV and HCV 56
Predictivity of frontal QRS-T angle for death in COVID-19 patients may differ by age 56
International comparisons of laboratory values from the 4CE collaborative to predict COVID-19 mortality 55
Spike-specific T-cell responses in patients with COVID-19 successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2 55
Seroprevalence and age-related susceptibility of TORCH infections in childbearing age women: a 5-year cross-sectional retrospective study and a literature review 55
Genomic organization and characterization of the white locus of the Mediterranean fruitfly, Ceratitis capitata 55
Intron size polymorphism of the Adh(1) gene parallels the worldwide colonization history of the Mediterranean fruit fly, Ceratitis capitata 55
Genetic differentiation, gene flow and the origin of infestations of the medfly, Ceratitis capitata 55
Unboosted Atazanavir for Treatment of HIV Infection Rationale and Recommendations for Use 55
Factors influencing the normalization of CD4+T-cell count, percentage and CD4+/CD8+T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy 55
Increase in Standard Cholesterol and Large HDL Particle Subclasses in Antiretroviral-Naive Patients Prescribed Efavirenz Compared to Atazanavir/Ritonavir 55
A systematic review on antibiotic therapy of cutaneous bacillary angiomatosis not related to major immunocompromising conditions: from pathogenesis to treatment 54
Evidence of Low Prevalence of Cystic Echinococcosis in the Catanzaro Province, Calabria Region, Italy. 54
Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection? 54
Characterization of long COVID temporal sub-phenotypes by distributed representation learning from electronic health record data: a cohort study 53
Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: An international multi-centre observational cohort study 53
Outcome of hbv screening and vaccination in a migrant population in southern italy 53
HIV/HTLV co-infection: frequency and epidemiological characteristics among patients admitted to an Italian hospital 53
"Solving the puzzle" of current HAART: What key strategic trials are needed? 53
Totale 6.524
Categoria #
all - tutte 184.244
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 184.244


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022871 0 3 12 236 30 17 41 216 58 104 146 8
2022/20232.569 684 110 20 276 286 244 14 160 402 169 166 38
2023/20241.126 236 146 78 76 69 288 36 24 26 25 60 62
2024/20253.713 542 273 136 136 235 459 67 142 458 232 333 700
2025/20268.525 396 1.060 751 1.405 724 312 1.261 489 1.038 719 268 102
2026/2027457 102 355 0 0 0 0 0 0 0 0 0 0
Totale 17.879